GLP-1 and Sleep Apnea: How Men Are Ditching the CPAP

If you're one of the estimated 25 million American men using a CPAP machine, GLP-1 medication may offer a path to sleeping without it. Tirzepatide (Zepbound) is now FDA-approved for obstructive sleep apnea — making it the first medication specifically indicated for a condition that overwhelmingly affects men.

The Sleep Apnea–Obesity Connection

Excess weight around the neck and upper airway is the primary cause of obstructive sleep apnea in adults. Weight loss of 10-15% — consistent with what GLP-1 medications achieve — can dramatically reduce apnea severity. Many men move from "severe" to "mild" or even below diagnostic threshold.

What the Research Shows

Clinical trials demonstrated that tirzepatide reduced AHI (apnea-hypopnea index) scores by 50-60% — a clinically meaningful reduction. Some patients eliminated their sleep apnea entirely. The weight loss also improved oxygen saturation, daytime sleepiness, and sleep quality scores.

The Cascade Effect

Better sleep from reduced apnea creates a positive cycle for men: improved testosterone production (testosterone is primarily produced during deep sleep), better workout recovery, improved mood and cognitive function, and more energy for daily life. Fixing sleep often feels like the single most impactful health improvement a man can make.